Corrigendum to 'Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States' [Clinical Lymphoma, Myeloma, and Leukemia Volume 24, Issue 8, August 2024, Pages 523-530].

Autor: Lurain K; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD. Electronic address: kathryn.lurain@nih.gov., El Zarif T; Yale University School of Medicine, New Haven, CT., Ramaswami R; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Nassar AH; Yale University School of Medicine, New Haven, CT., Adib E; Brigham and Women's Hospital, Department of Radiation Oncology, Boston, MA., Abdel-Wahab N; MD Anderson Cancer Center, Houston, TX., Chintapally N; Medstar/Georgetown-Washington Hospital Center, Washington, DC., Drolen CE; University of California Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA., Feldman T; John Theurer Cancer Center, Hackensack, NJ., Haykal T; Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, NC; Ohio State University Comprehensive Cancer Center, Columbus, OH., Nebhan CA; Vanderbilt University Medical Center, Nashville, TN., Kambhampati S; City of Hope Medical Center, Duarte, CA., Li M; Ohio State University Comprehensive Cancer Center, Columbus, OH., Mittra A; Ohio State University Comprehensive Cancer Center, Columbus, OH., Lorentsen M; University of North Carolina, Chapel Hill, NC., Kim C; Medstar Georgetown University Hospital, Washington, DC., Drakaki A; University of California Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA., Morse M; Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, NC., Johnson DB; Vanderbilt University Medical Center, Nashville, TN., Mangla A; University Hospital Seidman Cancer Center, Cleveland, OH., Dittus C; University of North Carolina, Chapel Hill, NC., Ravi P; Dana-Farber Cancer Institute, Boston, MA., Baiocchi RA; Ohio State University Comprehensive Cancer Center, Columbus, OH., Chiao EY; MD Anderson Cancer Center, Houston, TX., Rubinstein PG; John Stroger Cook County Hospital, Chicago, IL., Yellapragada SV; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine & Michael E. DeBakey VA Medical Center, Houston, TX., LaCasce AS; Dana-Farber Cancer Institute, Boston, MA., Sonpavde GP; Dana-Farber Cancer Institute, Boston, MA., Naqash AR; Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK, USA., Herrera AF; City of Hope Medical Center, Duarte, CA.
Jazyk: angličtina
Zdroj: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Dec; Vol. 24 (12), pp. 873.
DOI: 10.1016/j.clml.2024.10.011
Databáze: MEDLINE